Albireo Limited announced that Ron Cooper has joined the company as President and Chief Executive Officer. Mr. Cooper is a global biopharmaceutical leader with a track record of growing businesses, brands and organizations in the U.S. and Europe. He joins Albireo from Bristol-Myers Squibb (BMS), where he was President of Europe.